Ken Kelley – PaxVax

SOCAP Global June 16, 2009

Ken_KelleyKen Kelley is Chairman/CEO of PaxVax, a social biotech venture developing pill forms of vaccines. PaxVax business model is to run a for-profit in the First World supporting a non-profit in the Third World. Investors to date support this double bottom line model. PaxVax is currently raising a second round of capital to support clinical trials of its Swine Flu Pill vaccine. PaxVax is targeting influenza (Swine Flu H1N1, Bird Flu H5N1) as well as the world

Join the SOCAP Newsletter!